// Biotech and Pharma Therapeutics
Health systems’ websites still face uncertain regulatory terrain
October 8, 2024 / HIPAA Breach / User protection
City Therapeutics breaks ground with $135M and blueprints from RNAi expert John Maraganore
October 8, 2024 / City Therapeutics / Biotech Venture Capital / ARCH Venture Partners / John Maraganore
How extreme weather could lead to drug shortages
October 8, 2024 / Drug Shortages / Kidney Disease / Alzheimer’s / Supply Chain Disruptions
Weight loss gold rush: Developers vie for next blockbuster treatment
October 8, 2024 / Roche Obesity Strategy / Cardiovascular Renal Metabolism Therapies / Obesity Drug Market Opportunities / Metabolic
N.C. A&T, Merck Introduce High School Students to Biotechnology
October 1, 2024 / Home Health Worker Safety / Healthcare / North Carolina
// 4th Industrial Revolution
Echo IQ bags 510(k) for heart disease AI
October 8, 2024 / Echo IQ / Heart Disease / AI / Regulatory Approval
Amwell Integrates with Hello Heart to Offer Digital Cardiovascular Solution
October 8, 2024 / Amwell / Hello Heart / Cardiovascular Health
The Balance Between Promoting Data Sharing and Ensuring the Privacy and Security of Sensitive Health Information
October 8, 2024 / Data Sharing / User Protection / HIPPA
AthenaHealth Launch athenaOne for Behavioral Health
October 8, 2024 / AthenaHealth / AthenaOne / Patient Care / Telehealth
Kipu Health, Amazon Web Services partner to deliver AI to behavioral health sector Tool
October 8, 2024 / Kipu Health / Amazon / AI / Behavioral Health / Clinical Workflows
// Business & Markets
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
October 8, 2024 / GSK / Pfizer / RSV Vaccine / Sales Down
Digital mental health company Resilience Lab acquires Options MD
October 8, 2024 / 23andMe going private /CEO Acquisition / Stock Buyout
Execs, sale reps charged in $1.3B prescription drug operation
October 7, 2024 / Unlawful Distribution / Prescription Drugs
Maven Clinic Secures $125M to Expand Women’s and Family Health Services
October 8, 2024 / Maven Clinic / Women’s Health / Family Health
Genor Biopharma announces merger with Edding in Hong Kong
October 8, 2024 / Genor Biopharma / Hong Kong / Merger
// Legal & Regulatory
Compounders sue FDA for removing Eli Lilly’s tirzepatide from shortage list
October 8, 2024 / FDA / Compounding / Eli Lilly / Tirzepatide
MHRA clears Iqirvo as first medicine for rare liver disease
October 8, 2024 / MHRA / Iqirvo / Liver Disease / UK Drug Approval
PTC puts Friedreich ataxia drug’s past failures in the rearview with long-term data drop
October 8, 2024 / PTC Therapeutics / Friedreich’s Ataxia / FDA / Rare Diseases
Teva Prolia biosimilar accepted for review by FDA and EMA
October 8, 2024 / Teva Prolia / FDA / EMA / Drug Development
Neuvivo files NDA seeking FDA approval for ALS treatment
October 8, 2024 / FDA Approval / ALD Treatment / Neuvivo
// Research & Development
Merck’s Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
October 8, 2024 / Merck & Co / Keytruda / Head and Neck Cancer
Cedars-Sinai Joins Study to Address Cancer Disparities in Asian Americans
October 7, 2024 / Cedars-Sinai / Asian Americans / Cancer Study
Point Solution Fatigue? Zooming Out to the Population Level Can Help
October 8, 2024 / Population Level / Healthcare Savings / Healthcare Costs
‘Ongoing challenges’ force Pfizer to scrap oral RSV med from ReViral buyout
October 8, 2024 / Pfizer / ReViral / RSV / R&D
Sage continues downslide as Alzheimer’s study fails
October 8, 2024 / Sage Therapeutics / Alzheimer’s Study / Clinical Trials
// Politics
Popular proposals would result in no reductions, or modest reductions, in 2031 prices: CBO
October 8, 2024 / Congressional Budget Office / Inflation Reduction Act / Drug Prices
5 Things Healthcare Leaders Should Know About the 2024 Election
October 8, 2024 / Healthcare / 2024 Election
Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
Even Political Rivals Agree That Medical Debt Is an Urgent Issue
October 8, 2024 / Medical Debt / Bipartisan / Affordable Care Act
Biden’s FTC took on big tech, big pharma and more. What antitrust legacy will Biden leave behind?
October 2, 2024 / Biden / Big Tech / Big Pharma / Antitrust